MedTrace Logo

EUS-guided Ablation of Pancreatic Cyst Neoplasms

NCT02422147 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-12-17

No results posted yet for this study

Summary

This is a registry that will maintain prospective data on the clinical outcomes of all patients with pancreatic cyst lesions who undergo EUS-guided alcohol ablation.

Conditions

  • Pancreatic Cyst

Interventions

PROCEDURE

Ablation of PCL

All procedures are standard of care and will be undertaken using a curvilinear echoendoscope. The cyst will be punctured using a 22G needle and after subtotal evacuation of the cyst, injection is performed with a volume of alcohol that is equal to the quantity aspirated, and the cyst will be lavaged for 3 to 5 minutes. The injected ethanol will then be evacuated at the end of lavage, leaving just enough fluid to outline the cavity. A second ablative agent such as paclitaxel is then injected and left in the cyst cavity. At the completion of the procedure, the needle will be removed from the cyst cavity.

Sponsors & Collaborators

  • AdventHealth

    lead OTHER

Principal Investigators

  • Muhammad Hasan, MD · AdventHealth

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2024-12-12
Completion
2024-12-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02422147 on ClinicalTrials.gov